Skip to content

Vera Therapeutics VERA Total Current Assets

Total Current Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$11.73B+17.2%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$392.68M+4.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$480.24M+18.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$589.04M+156%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$784.74M+19.4%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's total current assets?
Vera Therapeutics (VERA) reported total current assets of $615.8M in Q1 2026.
How has Vera Therapeutics's total current assets changed year-over-year?
Vera Therapeutics's total current assets increased by 1.6% year-over-year, from $606.08M to $615.8M.
What is the long-term trend for Vera Therapeutics's total current assets?
Over 5 years (2020 to 2025), Vera Therapeutics's total current assets has grown at a 68.1% compound annual growth rate (CAGR), from $54.26M to $728.88M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.